Phase 1 Study to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Trial Profile

Phase 1 Study to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Completed
Phase of Trial: Phase I/II

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Insulin glargine/insulin lispro (Primary) ; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Adocia
  • Most Recent Events

    • 16 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
    • 18 Nov 2013 New trial record
    • 14 Nov 2013 Results from this trial are expected in the first quarter of 2014, according to an Adocia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top